FOXP3 and synovial sarcoma: Interestingly, the SR group had lower percentage of CD4+FoxP3+ T lymphocytes in comparison to SS group (12.5 ± 0.9% vs. 17.3 ± 1.4%, p = 0.001, Figure 2A).